论文部分内容阅读
Suppression of the autophagy-lysosomepathway as a novel cancer therapeutic strategy
【机 构】
：
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapo
【出 处】
：
2015中国转化医学大会暨中国转化医学联盟成立大会
【发表日期】
：
2015年期
其他文献
The use of human T lymphocytes genetically modified to express chimeric antigen receptors on their surfaces has emerged as a promising treatment strategy fo
会议
Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunother
λ-carrageenan is a seaweed polysaccharide which has been generally used as proinflammatory agent in the basic research, however, how the immunomodulating a
成体干细胞在机体损伤修复和组织再生中发挥重要作用。间充质干细胞(Mesenchymal stem cells,MSCs)是近年来备受关注的一类成体干细胞,具有跨胚层多向分化的潜能,参与多
会议
Pre-treatment with tumor cell-derived microparticles enhance the cytotoxicity of chemotherapeutic dr
Bladder cancer is the second most common genitourinary malignant disease in the USA, with an expected 69000 newly diagnosed cases each year, and 14 000 deat
会议
CART是指嵌合抗原受体(chimeric antigen receptor,CARs)修饰的T细胞,它能够以非MHC限制性的方式特异性识别并杀死癌细胞。其典型的CAR结构包括单链多样性片段ScFv (sing
会议
现阶段针对癌症的常规治疗主要包括手术治疗和放、化疗相结合的治疗方法,但因其治疗后并发症多、复发率转移率高、患者会承受巨大痛苦和对人体正常细胞组织也会产生巨大
There are two major approaches tothe pharmacological treatment of human disease.Western medicineseekstodiscover and develop drugs that target specific genes,rec
会议
复发转移是恶性肿瘤最本质的生物学行为特征，也是导致大多数肿瘤患者治疗失败和死亡的直接原因。随着对肿瘤免疫监视和免疫逃逸机制认识的不断深入，在常规治疗后，联合应用免
会议
Cytokine-induced killer cell-based chemoimmunotherapy for advanced non-small cell lung cancer: A sys
Aim: Cancer immunotherapy, especially cytokine-induced killer cell therapy,has flourished in recent years.However, clinical studies about immunotherapy in c
会议